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OBJECTIVES We sought to examine the incidence and possible factors for inducible intra-atrial reentrant
tachycardia (IART) in a group of patients after two stages of the Fontan sequence but before
the operation.
BACKGROUND Intra-atrial reentrant tachycardia occurs in 10% to 40% of patients after the Fontan operation.
No data are available regarding the potential for IART after the first two stages of the Fontan
sequence but before the operation.
METHODS The IART induction protocol included programmed extrastimulation and rapid atrial pacing,
with and without isoproterenol.
RESULTS The median age of the study group (n 5 44, 27 males) was 1.7 years (range 1.2 to 5.2). Forty
patients were in sinus rhythm. Twelve patients (27%) had inducible, sustained (.1 min)
IART. Three patients (8%) had inducible, nonsustained IART. Bivariate analysis revealed
that patients with sustained IART were significantly older at their second operation (median
0.54 vs. 0.40 years, p 5 0.05). Multivariate logistic modeling revealed that older age ($0.55
years) at the second palliative operation (p 5 0.04), older age ($1.95 years) at evaluation
before the Fontan sequence (p 5 0.04) and female gender (p 5 0.03) were independently
associated with sustained IART. A trend toward a greater frequency of sustained IART was
seen in those patients with moderate or severe atrioventricular valve regurgitation (p 5 0.07)
and in those with resection of the atrial septum (p 5 0.06).
CONCLUSIONS The rate of inducible, sustained IART in a group of patients before the Fontan operation is
27% and is associated with older age at the time of second-stage palliation, older age at
pre-Fontan evaluation and female gender. (J Am Coll Cardiol 2001;37:231–7) © 2001 by the
American College of Cardiology
Children with single-ventricle pathologic and physiologic
findings require either a two- or three-staged surgical
approach—the Fontan sequence—for optimal palliation.
The Norwood operation is performed in the first or second
week of life in those infants with a severely hypoplastic left
ventricle. In patients with a hypoplastic right ventricle, an
aortopulmonary anastomosis may be sufficient. At 6 to 12
months, the second stage, either a bidirectional Glenn
operation (BDG) or a hemi-Fontan procedure (HFP), is
performed. Usually between 18 and 36 months of life, the
final Fontan operation is performed, completing the bypass
of either the right or left hypoplastic ventricle (1). Intra-
atrial reentrant tachycardia (IART, also known as “inci-
sional” reentrant tachycardia ), which occurs in 10% to 40%
of patients, is a well-known sequela of the final stage-3
Fontan operation (2–7). A number of retrospective studies
have implicated sinus node dysfunction (4,8), atrioventric-
ular valve regurgitation (3,4), right atrial hypertension (9)
and distention (5), older age at Fontan operation (3,4,10)
and a longer follow-up interval (4,7) as factors that may
contribute to an increase in the frequency of IART. Several
modifications to the Fontan operation, including the extra-
cardiac conduit Fontan procedure, have been adopted in an
attempt to decrease the incidence of IART, but none of
them have convincingly been shown to be effective (2–
4,11,12). In addition, intracardiac electrophysiologic studies in
patients who have had the Fontan operation have found
abnormal sinus node function, prolonged atrial refractoriness,
delayed intra-atrial conduction, as well as sustained, inducible
IART in 23% (13). Canine models simulating the Fontan
operation (12) and endocardial mapping studies in patients
undergoing the Fontan operation (13) have suggested that this
final palliation for patients with single-ventricle anatomy alters
electrophysiologic properties of the atria, creating the substrate
for laboratory and clinical arrhythmias. The purpose of this
investigation was to determine whether the potential for IART
exists before the final stage 3 of the Fontan sequence.
METHODS
Study group. The study group consisted of all patients
with single-ventricle anatomy admitted to the University of
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Michigan Congenital Heart Center between March 18,
1998 and January 1, 2000 for the Fontan operation, who
had undergone their second-stage operation at our center.
Sixty-eight patients presented, 13 families declined partic-
ipation and 11 others had heart catheterization performed at
referring centers, and therefore were excluded from the
study group. The remaining 44 patients comprised the study
group. Patient demographic, echocardiographic and heart
catheterization data, as well as follow-up course, were
recorded. Twenty-eight patients had the Norwood opera-
tion; all were on cardiopulmonary bypass and all had right
atriotomy and resection of the atrial septum; none had
balloon atrial septostomy. The remainder of the patients
had aortopulmonary anastomosis. Second-stage palliations
were classified as HFP or BDG. The HFP consisted of
creating an anastomosis from the right atrial appendage to
the pulmonary arteries and placing an intra-atrial baffle
within the right atrium to direct superior vena cava (SVC)
blood flow to the atriopulmonary connection. The BDG
consisted of transecting the SVC, creating an anastomosis
from the cephalad portion of the SVC to the pulmonary
arteries in an end-to-side fashion and ligating the caudal
portion of the SVC. Both operations were performed while
the patient was supported with cardiopulmonary bypass and
included right atriotomy. The University of Michigan
Institutional Review Board for Investigations Using Human
Subjects approved the investigational protocol, and written,
informed consent was obtained from all the patients.
Electrophysiologic study. Electrophysiologic studies were
performed after diagnostic heart catheterization. Patients
were sedated with midazolam or ketamine, or both, as well
as morphine during the heart catheterization and electro-
physiologic study. A 4F or 5F quadripolar electrophysi-
ologic (Cordis Webster, Diamond Bar, California) catheter
was placed in the high right atrium for electrophysiologic
stimulation and recording. Access to the right atrium was
done using the inferior approach (n 5 24, femoral vein)
when possible, and using the superior approach (n 5 20,
right subclavian vein) when inferior access was not available.
Atrial stimulus strength was at twice the diastolic threshold
in milliamperes and 2 ms in pulse width duration.
Sinus node recovery time (SNRT) and total sinoatrial
conduction time (TSACT) (Strauss method) were mea-
sured as previously described (14). Atrial and atrioventric-
ular node refractory periods were obtained by programmed
extrastimulus coupled to sinus rhythm and to at least one
additional drive train, and atrioventricular node Wenck-
ebach periods were obtained by rapid atrial pacing, as
previously described (15). Stimulation and recording were
performed using a Bloom stimulator (Bloom Associates
Ltd., Norberth, Pennsylvania) and Quinton Electrophysi-
ologic laboratory equipment (Quinton Instrument Co.,
Bothell, Washington) or Electrophysiologic MedSystems
Workmate, Version 2.11.5 (Mt. Arlington, New Jersey). An
arrhythmia induction protocol was then performed with
both atrial burst (10- to 20-ms decrements) and ramp
pacing down to a cycle length of 150 ms. The arrhythmia
induction protocol was repeated during isoproterenol infu-
sion at 0.01 to 0.1 mg/kg body weight per minute to increase
the heart rate by 20% or .150 beats/min if the initial trial
did not initiate IART. The diagnosis of IART was made by
inducing the tachycardia by programmed extrastimulation
or rapid atrial pacing, or both, with the following charac-
teristics: nonsinus p wave morphology, constant intra-atrial
cycle length, rapid deflection atrial electrograms with iso-
electric intra-atrial baseline (Fig. 1), variable atrioventricular
conduction and conversion with overdrive pacing or direct
current cardioversion. Tachyarrhythmias were considered
sustained if they lasted .1 min. The arrhythmia induction
protocol was discontinued after an arrhythmia was induced.
Overdrive pacing was used to convert reentrant atrial
arrhythmias to sinus rhythm. Transthoracic direct current
cardioversion was used when overdrive pacing was unsuc-
cessful (n 5 1).
Statistical analysis. Statistical analysis was performed us-
ing Statview version 5.0 (Abacus Concepts Inc. Berkeley,
California) and SAS version 7.0 (SAS Institute Inc., Cary,
North Carolina) software packages. Univariate analysis was
performed on all variables. Normally distributed continuous
data are reported as the mean value 6 SD; nonparametric
data are reported as the median value (minimum, maxi-
mum). The primary outcome variable was inducibility of
sustained IART. Bivariate analysis to test for an association
was performed using the t test for parametric data and the
Kruskal-Wallis test for nonparametric data. Categorical
data were compared by using the Fischer exact test. In
addition, multivariate logistic modeling was performed. For
these models, age at second-stage palliation and age at
electrophysiologic study were divided at the 75th percentile
to form binomial variables. Logistic models were used to
test the independent odds of sustained IART with older age
at second-stage palliation, older age at electrophysiologic
study, moderate or greater atrioventricular valve regurgita-
tion and female gender. A p value #0.05 indicated statis-
tical significance.
RESULTS
The median age at the time of second-stage palliation was
0.45 years (range 0.18 to 1.4) and 1.7 years (range 1.2 to 5.2)
at the time of electrophysiologic study. The mean weight at
the time of electrophysiologic study was 11.0 kg (range 6.5
to 14.7). The diagnoses included hypoplastic left heart
Abbreviations and Acronyms
BDG 5 bidirectional Glenn operation
HFP 5 hemi-Fontan procedure
IART 5 intra-atrial reentrant tachycardia
SNRT 5 sinus node recovery time
SVC 5 superior vena cava
TSACT 5 total sinoatrial conduction time
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syndrome (n 5 23), pulmonary atresia with intact ventric-
ular septum (n 5 5), tricuspid atresia (n 5 3), double-inlet
left ventricle (n 5 3), unbalanced atrioventricular septal
defect (n 5 5), double-outlet right ventricle (n 5 3) and
Ebstein’s anomaly (n 5 2). Forty patients underwent HFP
and four patients underwent BDG as their second stage of
palliation.
Cardiac rhythm on the 12-lead electrocardiogram before
electrophysiologic study was sinus (upright p waves in leads
I and II, with inverted p waves in lead aVR) in 40 patients,
left atrial (inverted p waves in lead I, isoelectric p waves in
lead aVF and upright p waves in lead aVR) in 2 patients,
low right atrial (inverted p waves in leads I and II, with
upright p waves in lead aVR) in 1 patient and junctional (no
discernible p waves) in 1 patient. The mean basic cycle
length was 553 6 94 ms.
Twelve patients (27%) had inducible, sustained IART
(.1 min) at a mean cycle length of 203 6 17 ms (range 160
to 320), nine patients underwent HFP and two had the
BDG operation. The majority were induced with atrial
burst pacing (n 5 10) at a mean cycle length of 190 6 53 ms
(range 150 to 333); two patients were induced with pro-
grammed extrastimulation. Only two patients required iso-
proterenol infusion for the induction of an atrial arrhythmia.
Another three patients (8%) had inducible, nonsustained
IART, all after HFP; one required isoproterenol. One
patient developed clinical IART eight months after the
Fontan operation. This patient had sustained IART at the
time of electrophysiologic study, before the Fontan opera-
tion. Because of the low incidence of clinical IART in this
study group to date, no further statistical analysis to examine
for a possible relation between clinical and inducible, sus-
tained IART was performed.
We compared the electrophysiologic data of those pa-
tients with sustained IART to the data of those patients
without sustained IART (Table 1). Bivariate analysis re-
vealed that patients who had sustained IART were signifi-
cantly older at the time of their second palliative surgery
(median 0.54 vs. 0.40 years, p 5 0.05). Sustained IART was
seen more frequently in females than in males (50% vs. 19%,
p 5 0.06) and more frequently in patients with moderate or
severe atrioventricular valve regurgitation than in those with
no or mild cases of it (100% vs. 24%, p 5 0.07). No
statistically significant differences were found in the pa-
tients’ cardiac diagnoses, electrophysiologic variables, pul-
monary artery or venous pressure, pulmonary vascular resis-
tance, ventricular function, semilunar valve regurgitation or
type of second-stage palliation (HFP vs. BDG). Univariate
Figure 1. A representative surface electrocardiogram (ECG) and mid-right atrial intracardiac tracing (RA 1–2) from a study participant. The left panel
demonstrates sinus rhythm. The right panel demonstrates IART with low amplitude, biphasic p waves in lead I and upright, nonsinus p waves in leads
II and III, along with 2:1 atrioventricular conduction. I 5 ECG lead I; II 5 lead II; III 5 lead III; aVR 5 lead aVR; aVL 5 lead aVL; aVF 5 lead aVF;
RA 5 right atrial electrogram; A 5 atrial electrogram; V 5 ventricular electrogram.
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analysis demonstrated a 75th percentile cut-off value for age
at second-stage palliation at 0.55 years and for age at
electrophysiologic study at 1.95 years. Multivariate logistic
modeling revealed increased odds of sustained IART to be
independently associated with older age at second-stage
palliation ($0.55 years, odds ratio 6.8), older age at elec-
trophysiologic study ($1.95 years, odds ratio 6.8) and
female gender (odds ratio 7.4) (Table 2).
Twenty-eight patients had resection of the atrial septum
during the Norwood operation; another three patients had
resection at the time of their shunt procedure. Bivariate
analysis demonstrated a trend (p 5 0.06) toward a greater
incidence of sustained IART in patients with resection of
the atrium septum (42%), as compared with those without
resection (8%). In addition, the atrioventricular conduction
system (atrioventricular node and His-Purkinje system), as
indicated by the atrioventricular conduction system effective
refractory period (168 6 39 vs. 228 6 86 ms; p 5 0.005)
and by the Wenckebach cycle length (115 6 31 vs. 162 6
112 ms, p 5 0.06), was impaired in those patients with
resection as compared with those without it. This associa-
tion of atrioventricular conduction system impairment with
resection of the atrial septum was also present when one
compared patients with sustained IART to those without it
(Table 1).
DISCUSSION
Intra-atrial reentrant tachycardia has been well described in
the Fontan population. Much of the effort to treat and
prevent tachyarrhythmias has been focused on changes that
occur during and after the Fontan operation. Little is known
about the electrophysiologic and anatomic changes that
might occur in the atria of the single-ventricle heart before
the Fontan operation or after the second- and third-stage
operations. This study uncovered an incidence of inducible,
sustained IART before the Fontan operation similar to that
reported in retrospective studies (2–5,9) and/or invasive
electrophysiologic testing (16) after the Fontan operation,
and it delineated potential factors that, if present before the
Fontan operation, may potentiate the development of IART
in these patients. These factors are increased age at second-
stage palliation, increased age at electrophysiologic study
and the female gender.
Age. Durongpisitkul et al. (3) found that patients who
underwent the Fontan operation at ,3 years of age or .10
years of age had an increased risk of developing late-onset
supraventricular arrhythmias. Fishberger et al. (4) found
that atrial flutter was more likely to occur earlier if the
Fontan operation was performed at an older age. They also
found that a longer follow-up interval after the Fontan
operation was associated with a higher frequency of atrial
Table 1. Comparison of Patients With and Without Inducible, Sustained IART
Nonsustained IART Sustained* IART p Value
Age at second-stage surgery (years) 0.40 (0.18–0.92; n 5 32) 0.55 (0.26–1.4; n 5 12) 0.050
Age at EP study (years) 1.62 (1.16–2.42; n 5 32) 1.85 (1.5–5.2; n 5 12) 0.075
Gender (M/F) 27/5 6/6 0.059
Second-stage surgery (HFP/BDG) 30/2 10/2 0.28
Weight (kg) 10.7 6 1.7 (n 5 32) 11.7 6 1.7 (n 5 12) 0.084
Basic cycle length (ms) 539 6 101 (n 5 32) 590 6 57 (n 5 12) 0.11
mcSNRT (ms) 188 6 152 (n 5 30) 280 6 243 (n 5 11) 0.15
AERP (ms) 180 6 35 (n 5 31) 187 6 33 (n 5 12) 0.59
AVERP (ms) 202 6 61 (n 5 31) 232 6 74 (n 5 12) 0.18
TSACT (ms) 129 6 68 (n 5 27) 191 6 138 (n 5 10) 0.076
AV Wenckebach cycle length (ms) 255 6 55 (n 5 31) 297 6 95 (n 5 11) 0.081
PAP (mm Hg) 10.8 6 2.8 (n 5 32) 11.5 6 2.1 (n 5 12) 0.40
PVP (mm Hg) 6.6 6 3.7 (n 5 31) 5.4 6 1.9 (n 5 12) 0.30
PVR (Woods units 3 m2) 1.8 6 0.7 (n 5 30) 2.4 6 1.1 (n 5 11) 0.12
AV valve regurgitation (none or mild/moderate or greater) 32/0 10/2 0.070
Semilunar valve regurgitation (none or mild/moderate or greater) 30/2 12/0 0.37
Ventricular function (good to mildly depressed/moderately depressed or greater) 32/0 12/0 0.44
Atrial septum resection (yes/no) 20/11 11/1 0.06
AVERP (ms) with resection of atrial septum 217 6 66 (n 5 17) 244 6 71 (n 5 13) 0.005†
AVERP (ms) without resection of atrial septum 170 6 35 (n 5 12) 150 (n 5 1)
Wenckebach CL (ms) with resection of atrial septum 261 6 61 (n 5 18) 305 6 91 (n 5 12) 0.09‡
Wenckebach CL (ms) without resection of atrial septum 237 6 33 (n 5 11) 200 (n 5 1)
*Sustained (.1 min). †Sustained IART with resection versus nonsustained IART and no resection. ‡Sustained IART with resection versus nonsustained IART and no resection.
Parametric data are expressed as the mean value 6 SD; nonparametric data are expressed as the median value (minimum-maximum).
AERP 5 atrial effective refractory period; AV 5 atrioventricular; AVERP 5 atrioventricular effective refractory period; BDG 5 bidirectional Glenn operation; EP 5
electrophysiologic; HFP 5 hemi-Fontan procedure; IART 5 intra-atrial reentrant tachycardia; mcSNRT 5 maximal corrected sinus node recovery time; PAP 5 pulmonary
artery pressure; PVP 5 pulmonary venous pressure; PVR 5 pulmonary vascular resistance; TSACT 5 total sinoatrial conduction time.
Table 2. Odds Ratios of Independent Variables Associated
With Inducible, Sustained Intra-atrial Reentrant Tachycardia
Odds Ratio
(95% Confidence Interval) p Value
Age at second-stage
palliation $0.55 years
6.8 (1.2–39) 0.05
Age at electrophysiologic
study $1.95 years
6.8 (1.2–39) 0.04
Female gender 7.4 (1.2–44) 0.04
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flutter. In a large study by Garson et al. (17), the incidence
of atrial flutter increased with age at follow-up among
children with cardiac disease. We found similar results
during a 10-year retrospective study of patients who had the
Fontan operation (6). Older age at operation and longer
duration of follow-up were associated with IART, regard-
less of single-ventricle anatomy or type of Fontan operation.
This current prospective study confirms age as a determi-
nant in the frequency of sustained IART and is in agree-
ment with previous retrospective studies. Importantly, it
also suggests that the anatomic and electrophysiologic
changes that occur in the atria of the patient with a single
ventricle may be as much dependent on time or other
operative interventions as they are dependent on changes
ascribed to the Fontan operation per se.
Female gender. Females are known to a exhibit faster rest
heart rate, longer corrected QT interval (18) and higher
incidence of torsade de pointes as compared with males
(19–21). Our study found an association between female
gender and inducible IART, even though females com-
prised only 25% of the group. Further analysis was per-
formed to determine whether our female patients differed
from the male patients in terms of age or diagnosis;
however, no differences were found. The clinical signifi-
cance linking female gender and sustained IART is cur-
rently unknown. Our study group consists of very young
patients with severe forms of congenital heart disease; thus,
it is not comparable to adult patients in whom the gender
differences have been observed.
Atrioventricular valve regurgitation. Moderate or severe
atrioventricular valve regurgitation, as shown on the echo-
cardiogram, exhibited a trend toward a statistically signifi-
cant increase in the risk of sustained IART. Atrial disten-
tion secondary to atrioventricular valve regurgitation has
been found to change the electrophysiologic properties of
the atria predisposing to supraventricular arrhythmias
(22,23). Several retrospective studies of Fontan patients
with clinical IART have found that atrioventricular valve
regurgitation and increased right atrial size increase the
likelihood of IART (3–5). It would seem reasonable that
atrioventricular valve regurgitation in the pre-Fontan pop-
ulation would increase the risk of sustained IART. How-
ever, in our group, right atrial enlargement is not uniform.
In fact, because the flow pathway of HFP and BDG largely
bypasses the atria, in the absence of atrioventricular valve
regurgitation, right atrial size is relatively preserved. The
lack of uniform atrial enlargement in our patients with
sustained IART would suggest that this physiologic change
is not essential to the development of IART. This interpre-
tation is supported by studies comparing the total cavopul-
monary connection in the Fontan operation to the atriopul-
monary connection Fontan modification. Although atrial
enlargement is common after the atriopulmonary connec-
tion in the Fontan operation, but not after the total
cavopulmonary connection Fontan modification, large ret-
rospective studies have not found a significant difference in
the occurrence of atrial arrhythmias between the two groups
(3,4).
Electrophysiologic data. Kurer et al. (16) previously re-
ported the electrophysiologic changes that occur at a mean
of two years after the Fontan operation. Intracardiac elec-
trophysiologic studies revealed abnormal sinus node func-
tion, prolonged atrial refractoriness, delayed intra-atrial
conduction and inducible atrial arrhythmias. Sustained
IART was induced by programmed atrial stimulation in 7
(23%) of 30 study patients. One patient had atrioventricular
node reentrant tachycardia. Nonsustained atrial arrhythmias
occurred in an additional 10%. These authors concluded
that prolonged atrial conduction and right atrial enlarge-
ment could increase the probability that atrial arrhythmias
will develop.
In our study, atrial conduction was not directly measured.
However, the basic cycle length, maximal corrected SNRT
and TSACT tended to be longer in the sustained IART
group (Table 1). As measures of sinus node function, these
data suggest that sinus node impairment may be associated
with sustained IART. Manning et al. (8) reported similar
findings of altered sinoatrial node function after placement
of a cavopulmonary shunt as a factor associated with atrial
arrhythmias after the Fontan operation. In their comparison
of patients who directly had the Fontan operation with
those who underwent the staged Fontan operation, the
latter group had a greater incidence of atrial arrhythmias
after the Fontan procedure. Injury to the sinus node or sinus
node artery at the time of the second stage was proposed as
a possible cause of sinus node dysfunction. Our study is
congruent with this observation and supports the idea that
second-stage palliation may be as important as the Fontan
operation for creating the substrate for IART. Interestingly,
although HFP places the sinus node and sinus node artery
at greater risk, as compared with BDG, no significant
difference was found in the incidence of sustained IART. In
fact, the patients who underwent BDG, albeit only four,
had a significantly longer maximal corrected SNRT (389 6
347 vs. 194 6 152 ms, p 5 0.041). However, other
measures of sinus node function in the BDG group were not
prolonged.
Fishberger et al. (4) found that the presence of sinus node
dysfunction after the Fontan operation was associated with
a higher incidence of atrial flutter. Studies of sinus node
dysfunction, including animal models and retrospective
studies, have primarily focused on changes that occur after
the Fontan operation. Our data suggest that sinus node
dysfunction may occur before the Fontan operation, war-
ranting further investigation into surgical techniques per-
formed during HFP and BDG, or earlier palliations.
Resection of the atrial septum. All patients had atriotomy
at the second stage (HFP or BDG); therefore, no analysis or
inference can be made about the impact of an atrial free wall
incision on the incidence of IART. In contrast, resection of
the atrial septum performed at the first stage in 31 patients
significantly altered atrioventricular conduction, but not
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sinus node function, particularly in those who later had
inducible IART. This observation suggests that interruption
of atrial septal tissue providing input to the atrioventricular
node, as well as interruption of the preferential conducting
pathways between the sinus and atrioventricular nodes, can
alter the electrophysiologic properties at and around the
atrioventricular node, potentially contributing to an ar-
rhythmogenic substrate. Abnormalities in the electrophysi-
ologic properties of the atria that may provide the substrate
for arrhythmias have been shown to exist both before and
after repair of much simpler defects, such as ostium secun-
dum atrial septal defects (24–29). This observation under-
scores both the importance of the pre-Fontan findings in
this study and the potential for creating a local environment
that supports the emergence of clinical arrhythmias.
Follow-up. The correlation between inducible IART and
the development of clinical IART is not known. It is
interesting to note that the patient who was found to have
clinical IART after the Fontan operation had inducible,
sustained IART during the electrophysiologic study before the
Fontan operation. As discussed previously, longer follow-up
intervals are associated with an increased frequency of clinical
IART. Further follow-up is necessary to determine a possible
correlation between inducible and clinical IART.
Study limitations. The intent of this study was to investi-
gate the inducibility of sustained IART before the Fontan
operation. Programmed electrophysiologic testing was per-
formed during clinically indicated heart catheterizations
before the Fontan operation. Venous access was limited to
that which was required to acquire hemodynamic and
angiographic data. Thus, complete access to the right
atrium was not available. Mapping of the intra-atrial reen-
trant circuit was not possible; therefore, the location of the
reentry circuit, the heterogeneity of atrial refractoriness and
the atrial conduction velocity could not be determined.
Furthermore, the variety of single-ventricle anatomy com-
prising the study group does not allow for inferences to be
made about any specific lesion.
Conclusions. Intra-atrial reentrant tachycardia is a well-
described and hemodynamically compromising sequela of
the Fontan operation. To our knowledge, this is the first study
to investigate the inducibility of sustained IART and its risk
factors before the Fontan operation. The findings suggest that
the electrophysiologic substrate for IART exists before the
Fontan operation and may be influenced by resection of the
atrial septum. Furthermore, patients who do not progress
beyond the second stage of palliation may still be at risk of
developing IART. Finally, these findings suggest that factors
that give rise to the atrial arrhythmias after the Fontan
operation may not be attributed to the Fontan operation alone.
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